Chiesi USA, Inc. v. Aurobindo Pharma USA, Inc.
CHIESI USA, INC. and CHIESI FARMACEUTICI S.P.A. |
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LTD. |
23-1171 |
November 21, 2022 |
U.S. Court of Appeals, Federal Circuit |
Patent - (ANDA) (Fed. Qst.) |
Opinions
We have the following opinions for this case:
Description |
---|
CHIESI USA, INC. v. AUROBINDO PHARMA USA, INC. |
Docket Report
This docket was last retrieved on November 29, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 4 ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [ # 3 ] filed by Appellants Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. and Appellees Chiesi USA, Inc. and Chiesi Farmaceutici S.p.A..; issuing mandate. Service as of this date by the Clerk of Court. [887019] [ALK] [Entered: 11/29/2022 04:25 PM] |
Filing 3 MOTION of Appellants Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. and Appellees Chiesi Farmaceutici S.p.A. and Chiesi USA, Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). Service: 11/22/2022 by email. [886066] [23-1171] [Steven Moore] [Entered: 11/22/2022 01:33 PM] |
Filing 2 Entry of appearance for Steven J. Moore; James E. Nealon as counsel for Appellants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.. Service: 11/21/2022 by email. [885515] [23-1171] [Steven Moore] [Entered: 11/21/2022 02:13 PM] |
Filing 1 Appeal docketed. Received: 11/15/2022. [885399] Entry of Appearance is due on 12/05/2022. Certificate of Interest is due on 12/05/2022. Docketing Statement is due on 12/05/2022. Appellants' brief is due on 01/20/2023. [ALK] [Entered: 11/21/2022 11:42 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.